Ronglin Kan

机构：Tianjin Medical University Cancer Institute and Hospital

发表论文 3 篇 · 总被引 34 次 · h-index 2

代表论文

• USP9X integrates TGF-β and hypoxia signalings to promote ovarian cancer chemoresistance via HIF-2α-maintained stemness (2025 · Cell Death and Disease · 被引 17)
• Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study (2021 · Journal of Pharmaceutical Sciences · 被引 16)
• Methyltransferase like 3 promotes thyroid folliculogenesis via coordinating cell differentiation and polarization (2026 · Journal of Translational Internal Medicine)